Silverman Joshua 4
4 · Petros Pharmaceuticals, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Petros Pharmaceuticals (PTPI) Director Joshua Silverman Receives Award
What Happened
- Joshua Silverman, a director of Petros Pharmaceuticals, was granted 4,375,000 restricted shares (transaction code A) on 2026-06-05. The shares were acquired at $0.00 per share (total cash paid $0), reflecting a compensation award rather than a market purchase.
Key Details
- Transaction date: 2026-06-05; Price: $0.00 per share; Shares granted: 4,375,000.
- Vesting: 50% vested on the grant date; the remaining 50% vests on the six‑month anniversary, subject to continued service (per footnote).
- Shares owned after the transaction: not specified in the filing.
- Filing timeliness: filing covers the transaction date and was filed the same day (no late filing indicated).
- Transaction type: Award/Grant (Form 4 code A). No tax‑withholding or sale reported in this filing.
Context
- This is an equity compensation award (restricted stock) tied to service; it is not a market purchase or sale. Such grants are commonly used for compensation and retention and do not by themselves signal insider buying or selling activity.
Insider Transaction Report
Form 4
Silverman Joshua
Director
Transactions
- Award
Common Stock
[F1]2026-06-05+4,375,000→ 8,790,450 total
Footnotes (1)
- [F1]Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing services to the Issuer on such vesting date.
Signature
/s/ Joshua Silverman|2026-06-05